In this context, the strategy of targeting BAG3 protein secreted by cancer cells seems to be promising for its effect in negatively modulating both TAMs and CAFs; it is worth noting that the amount of tumor stroma and collagen fibers is decreased in murine pancreatic cancer when treated with an anti‐BAG3 monoclonal antibody. The gene discussed is BAG3; the disease is pancreatic neoplasm.